Severe ADAMTS13 deficiency and the presence of inhibitory antibodies to ADAMTS13 is essential for the diagnosis of iTTP, and to differentiate it from other thrombotic microangiopathies (TMAs) [11,12]. This evidence concerns the gene ADAMTS13 and thrombotic microangiopathy.